COVID-19 (SARS-CoV-2 infection) Infections and Infestations
Conditions
Interventions
The researchers plan to undertake an observational cohort study using routine electronic data capture from people using the emergency care system (via 111 and 999 calls, ambulance conveyance, or hospi
Sponsors
Sheffield Teaching Hospitals NHS Foundation Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All adults and children with suspected respiratory infection during a pandemic who present at the emergency department of a participating hospital, call 111 or 999 services or are attended by a 999 ambulance from a participating ambulance trust. Patients will be eligible for inclusion if they meet the current clinical diagnostic criteria; 1. Fever (pyrexia =38°C) or a history of a fever 2. Influenza-like illness (two or more of cough, sore throat, rhinorrhoea, limb or joint pain, headache, vomiting or diarrhoea or severe and/or life-threatening illness suggestive of an infectious process. (Or if they meet any future clinical diagnostic criteria recommended by the Department of Health).
Exclusion criteria
Exclusion criteria: Participants will only be excluded from the study if they request to be.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patients who die or require respiratory, cardiovascular or renal support will be defined as having an adverse outcome. If patients survive to 30 days without requiring respiratory, cardiovascular or renal support they will be defined as having no adverse outcome. If a severe pandemic leads to hospital resources being overwhelmed the researchers will categorise patients as having an adverse outcome if they were deemed to have needed respiratory, cardiovascular or renal support but were denied this due to lack of resources; Timepoint(s): 30 days | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
England, Northern Ireland, Scotland, United Kingdom, Wales
Outcome results
None listed